746 related articles for article (PubMed ID: 8158680)
1. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
[TBL] [Abstract][Full Text] [Related]
2. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
[TBL] [Abstract][Full Text] [Related]
3. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the head and neck: a 5- to 20-year experience with preoperative chemotherapy, uncompromised surgery, and selective radiotherapy.
Loré JM; Kaufman S; Sundquist N; Chary KK
Ann Surg Oncol; 2003 Jul; 10(6):645-53. PubMed ID: 12839849
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.
Zorat PL; Paccagnella A; Cavaniglia G; Loreggian L; Gava A; Mione CA; Boldrin F; Marchiori C; Lunghi F; Fede A; Bordin A; Da Mosto MC; Sileni VC; Orlando A; Jirillo A; Tomio L; Pappagallo GL; Ghi MG
J Natl Cancer Inst; 2004 Nov; 96(22):1714-7. PubMed ID: 15547184
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer.
Zidan J; Kuten A; Rosenblatt E; Robinson E
Oral Oncol; 1997 Mar; 33(2):129-35. PubMed ID: 9231171
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034.
Laramore GE; Scott CB; al-Sarraf M; Haselow RE; Ervin TJ; Wheeler R; Jacobs JR; Schuller DE; Gahbauer RA; Schwade JG
Int J Radiat Oncol Biol Phys; 1992; 23(4):705-13. PubMed ID: 1618662
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
13. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL;
N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012
[TBL] [Abstract][Full Text] [Related]
15. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study.
Lewin F; Damber L; Jonsson H; Andersson T; Berthelsen A; Biörklund A; Blomqvist E; Evensen JF; Hansen HS; Hansen O; Jetlund O; Mercke C; Modig H; Overgaard M; Rosengren B; Tausjö J; Ringborg U
Radiother Oncol; 1997 Apr; 43(1):23-8. PubMed ID: 9165133
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study.
Chougule PB; Suk S; Chu QD; Leone L; Nigri PT; McRae R; Lekas M; Barone A; Bhat D; Bellino J
Cancer; 1994 Oct; 74(7):1927-32. PubMed ID: 8082098
[TBL] [Abstract][Full Text] [Related]
18. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.
Pinnarò P; Cercato MC; Giannarelli D; Carlini P; Del Vecchio MR; Impiombato FA; Marzetti F; Milella M; Cognetti F
Ann Oncol; 1994 Jul; 5(6):513-9. PubMed ID: 7918123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
